Table 2.
Article |
---|
General information |
Affiliation (e.g., academic, commercial, public) |
Country of corresponding author |
Number of authors |
Journal + impact factor |
Disease area(s) (ICD-Code[s]) |
Type of intervention (e.g., drug treatment, surgical procedure) |
Scope of SR-HE (only SR-HE/SR-HE and primary CEA/SR-HE to inform primary CEA) |
If only SR-HE: indicated purpose of systematic review |
Study registered or published protocol available (not stated/stated) |
Consideration of reporting guideline (e.g., PRISMA) |
Statement of research question and formulated eligibility criteria |
Research question (not stated/stated) |
Eligibility criteria (PICOS + further [specify]) |
Economic study types included |
Literature search strategy |
Information sources (databases, reference lists of relevant records, etc.) |
Search terms/filters + explanation when economic terms missing (e.g., joint review for clinical and economic effectiveness) |
Search limits (time period, language, publication type, etc.) |
Study selection |
Flow of study selection described (yes/no) |
Study selection illustrated in flow chart (yes/no) |
Duplicate study selection (yes/no/unclear) + method (e.g., all independently/quality assurance of sample) + mechanism to resolve disagreement |
Technical support for study selection (e.g., software) |
Data extraction |
Data extraction method (e.g., standardized data extraction form) |
Duplicate data extraction (yes/no/unclear) + method (e.g., all independently/quality assurance of sample) + mechanism to resolve disagreement |
Data items extracted |
Technical support for data extraction (e.g., software) |
Assessment of methodological study quality |
Assessment of methodological study quality on study level (yes/no/unclear) + assessment tool |
Duplicate quality assessment (yes/no/unclear) + method (e.g., all independently/quality assurance of sample) + mechanism to resolve disagreement |
Assessment of generalizability/transferability/applicability |
Assessment of generalizability/transferability/applicability (yes/no/unclear) + assessment tool |
Duplicate generalizability/transferability/applicability assessment (yes/no/unclear) + method (e.g., all independently/quality assurance of sample) + mechanism to resolve disagreement |
Presentation of cost data |
Presentation of cost data (as reported/inflated/currency converted) |
Method for data synthesis |
Data synthesis |
Further remarks |
CEA cost-effectiveness analysis; PICOS patient, intervention, comparison, outcome, setting; PRISMA Preferred Reporting Items for Systematic review and Meta-Analysis; SR-HE systematic review of health economic evaluations